Supplement safety · public sources

Magnesium safety

FDA adverse-event reports, NIH guidance on interactions, and registered trials.

What public sources say about the safety of magnesium: FDA adverse-event reports, NIH guidance on interactions with medicines, and the registered trials that test it.

⚠️
Research information, not medical advice. Supplements can interact with prescription medicines and affect conditions. Check with a pharmacist or your own clinician before starting or stopping one. Nothing here is a dose recommendation.

Interactions and safety, in NIH's words

Magnesium may interact with certain medications, such as oral bisphosphonates, tetracyclines, and quinolone antibiotics. In addition, some medications, including diuretics and proton pump inhibitors, can affect magnesium status.

Several types of medications have the potential to interact with magnesium supplements or affect magnesium status. A few examples are provided below. People who are taking these and other medications on a regular basis should discuss their magnesium intakes with their health care providers.

Magnesium-rich supplements or medications can decrease the absorption of oral bisphosphonates, such as alendronate (Fosamax), that are used to treat osteoporosis [61]. Taking magnesium-rich supplements or medications at least 2 hours before or after oral bisphosphonates can minimize this interaction [57].

Medicines covered in that section: Bisphosphonates, Antibiotics, Diuretics, Proton pump inhibitors.

Quoted from the “Interactions with Medications” section: NIH Office of Dietary Supplements, health-professional fact sheet, retrieved 2026-11-16. Read the full page for the complete list and references.

FDA adverse-event reports (CAERS)

Reports are not rates. CAERS counts voluntary reports to the FDA from consumers, clinicians and companies. A report means someone linked a health problem to a product, not that the product caused it. There is no denominator: how many people took the product is unknown, so these numbers cannot show how common a problem is, and they cannot be compared between products. Popular products attract more reports.
684reports naming it in a suspect product
377where the product is named for it alone
2007–2026years covered, single-ingredient reports

Matching rule: reports in the dietary-supplement category where a product marked "suspect" has a brand name containing “MAGNESIUM”. Products that contain it without naming it are missed. Reports where it was only taken alongside the suspect product are not counted.

Combination products: 307 of the reports involve only products whose name lists another ingredient, such as calcium or a multivitamin. Their reactions may come from that other ingredient or from the tablet itself, so the reactions below count only the 377 reports where a product is named for magnesium alone. This split is made from product names and can misfile some products. Most-reported products: Magnesium (29); Citracal Plus Magnesium (27); Citracal Calcium + D Slow Release 1200 (25); Phillips' Laxative Dietary Supplement (21); Slow-Mag (19); Citracal Calcium+ D Slow Release 1200 (16).

Most reported reactions, single-ingredient reports
Most reported reactions (single-ingredient products)Reports
Diarrhoea46
Nausea31
Choking31
Dyspnoea30
Vomiting23
Dizziness22
Death22
Headache19
Hypersensitivity18
Foreign body17
Loss of consciousness16
Pain14

Outcomes recorded in these reports (a report can have several): Other Serious or Important Medical Event (271), Hospitalization (86), Other Serious Outcome (55), Visited Emergency Room (51), Visited a Health Care Provider (45), Life Threatening (26), Death (22), Disability (16).

Source: openFDA food and supplement adverse events (CAERS), retrieved 2026-11-16.

Registered trials

22 trials in the non-drug evidence map test this class of supplement. Trials with posted results are listed first; each shows the condition it was registered for. A trial testing it in one condition says nothing about another.

All supplement safety pages Non-drug evidence map